ALFRY (Alfresa Holdings) Piotroski F-Score: 7 (As of Jul. 01, 2026) — Near Median


ALFRY Alfresa Holdings Corp ALFRY
75 GF Score
Price $13.80
GF Value $16.31
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Alfresa Holdings Piotroski F-Score?

Alfresa Holdings ALFRY 75 Piotroski F-Score is 7 as of Jul. 01, 2026, which is at its 10-year median of 7.00. GuruFocus rates ALFRY with a GF Score™ of 75/100 and a GF Value™ of $16.31 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 112 Medical Distribution companies, Alfresa Holdings ranks better than 89.29% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Alfresa Holdings has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Alfresa Holdings's Piotroski F-Score or its related term are showing as below:

ALFRY' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 7   Max: 9
Current: 7

During the past 13 years, the highest Piotroski F-Score of Alfresa Holdings was 9. The lowest was 4. And the median was 7.

Alfresa Holdings  (OTCPK:ALFRY) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Alfresa Holdings Piotroski F-Score Related Terms


Alfresa Holdings Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Alfresa Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alfresa Holdings Piotroski F-Score Chart

Alfresa Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.00 5.00 7.00 5.00 7.00

Alfresa Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 0.00 0.00 0.00 7.00

ALFRY vs MCK, CAH, COR: Piotroski F-Score Comparison

For the Medical Distribution subindustry, Alfresa Holdings's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alfresa Holdings Piotroski F-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Alfresa Holdings's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Alfresa Holdings's Piotroski F-Score falls into.


ALFRY
75GF Score
Alfresa Holdings Corp ALFRY
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was $263 Mil.
Cash Flow from Operations was $243 Mil.
Revenue was $19,561 Mil.
Gross Profit was $1,373 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (9659.923 + 9497.04) / 2 = $9578.4815 Mil.
Total Assets at the begining of this year (Mar25) was $9,660 Mil.
Long-Term Debt & Capital Lease Obligation was $214 Mil.
Total Current Assets was $7,306 Mil.
Total Current Liabilities was $5,914 Mil.
Net Income was $184 Mil.

Revenue was $19,865 Mil.
Gross Profit was $1,435 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (9662.519 + 9659.923) / 2 = $9661.221 Mil.
Total Assets at the begining of last year (Mar24) was $9,663 Mil.
Long-Term Debt & Capital Lease Obligation was $228 Mil.
Total Current Assets was $7,343 Mil.
Total Current Liabilities was $6,004 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Alfresa Holdings's current Net Income (TTM) was 263. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Alfresa Holdings's current Cash Flow from Operations (TTM) was 243. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=263.078/9659.923
=0.02723396

ROA (Last Year)=Net Income/Total Assets (Mar24)
=183.748/9662.519
=0.01901657

Alfresa Holdings's return on assets of this year was 0.02723396. Alfresa Holdings's return on assets of last year was 0.01901657. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Alfresa Holdings's current Net Income (TTM) was 263. Alfresa Holdings's current Cash Flow from Operations (TTM) was 243. ==> 243 <= 263 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=213.842/9578.4815
=0.02232525

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=227.845/9661.221
=0.02358346

Alfresa Holdings's gearing of this year was 0.02232525. Alfresa Holdings's gearing of last year was 0.02358346. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=7305.863/5914.154
=1.23531836

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=7342.772/6004.129
=1.22295374

Alfresa Holdings's current ratio of this year was 1.23531836. Alfresa Holdings's current ratio of last year was 1.22295374. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Alfresa Holdings's number of shares in issue this year was 181.786. Alfresa Holdings's number of shares in issue last year was 185.637. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1373.055/19561.452
=0.07019188

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1435.197/19865.146
=0.07224699

Alfresa Holdings's gross margin of this year was 0.07019188. Alfresa Holdings's gross margin of last year was 0.07224699. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=19561.452/9659.923
=2.02501117

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=19865.146/9662.519
=2.05589723

Alfresa Holdings's asset turnover of this year was 2.02501117. Alfresa Holdings's asset turnover of last year was 2.05589723. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+1+1+1+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Alfresa Holdings has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Alfresa Holdings (ALFRY) has a Piotroski F-Score of 7 as of Jul. 01, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Alfresa Holdings and its competitors. This is near median its historical median of 7.00. Over the past decade, Alfresa Holdings' Piotroski F-Score has ranged from 4.00 to 9.00. According to the industry distribution chart, Alfresa Holdings ranks #12 out of 112 companies in the Medical Distribution industry, placing it in the top 10.7%.
Is Alfresa Holdings' Piotroski F-Score too high?
Alfresa Holdings' current Piotroski F-Score of 7 is near median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. The Medical Distribution industry median Piotroski F-Score is 5.00. Alfresa Holdings' value of 7 is 40% above this industry median. Based on the distribution chart, Alfresa Holdings ranks #12 out of 112 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Alfresa Holdings has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alfresa Holdings' Piotroski F-Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Alfresa Holdings ranks #12 out of 112 companies for Piotroski F-Score. This places Alfresa Holdings in the top 11% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Alfresa Holdings' value of 7 is 40% above this benchmark. Historically, Alfresa Holdings' own Piotroski F-Score has ranged from 4.00 to 9.00 over the past decade. While the company's 10-year median is 7.00 vs. the industry median of 5.00, Alfresa Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Distribution company?
The median Piotroski F-Score among Medical Distribution companies is 5.00, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alfresa Holdings's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Alfresa Holdings and its competitors. For the Medical Distribution industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alfresa Holdings's current Piotroski F-Score is 7, which is near median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alfresa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Alfresa Holdings (ALFRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.31, compared to a current price of $13.80 — trading 15.4% below its estimated fair value. The current Piotroski F-Score is 7, which is near median its 10-year median of 7.00 and 40% above the Medical Distribution industry median of 5.00. Alfresa Holdings' overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Alfresa Holdings (ALFRY), the current Piotroski F-Score is 7 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alfresa Holdings (ALFRY) Overvalued in 2026?

Based on GuruFocus' analysis, Alfresa Holdings stock appears to be undervalued. The current stock price of $13.80 is trading 15.4% below its estimated GF Value™ of $16.31. GuruFocus considers Alfresa Holdings to be Modestly Undervalued.

Key valuation signals for ALFRY:

  • Piotroski F-Score: 7 (near median its 10-year median of 7.00)
  • GF Value™: $16.31 vs. price of $13.80 (15.4% below fair value)
  • GF Score™: 75/100 with 1 warning sign
  • Industry Position: 40% above the Medical Distribution median (#12 of 112)

No single metric tells the full story. See the ALFRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alfresa Holdings Business Description

Other Exchanges 2784:Japan
Address 1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004
Alfresa Holdings Corp is engaged in the pharmaceutical distribution and related businesses. The company operates through four reportable segments: Wholesale business of medical drugs, Self-Medication Wholesale Business, Pharmaceutical Manufacturing Business, and Medical-Related Business. Its operations include the wholesale of ethical and over-the-counter pharmaceuticals, the manufacture and sale of pharmaceuticals, medical testing reagents, and medical equipment, as well as the operation of dispensing pharmacies.
75GF Score

Get the complete analysis for ALFRY

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.80
Price
$16.31
GF Value